CLOVER HEALTH INVESTMENTS, CORP. /DE vs CENTENE CORPORATION, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CLOV and CNC diverge most: on return on invested capital, CLOV reads -13.3% and CNC reads 3.7%; on debt / equity, CLOV reads 0.00 and CNC reads 0.71. The rest of the comparable metrics sit closer together. What CLOV's price implies is an extreme bet versus history and the cohort (earnings-power basis). What CNC's price implies is a bet that sits within the historical range (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | CLOV | CNC |
|---|---|---|
| Price | $4.16 | $62.19 |
| Market cap | $2.2B | $30.9B |
| Sector | Managed Care | Managed Care |
| Stage | Growth | Growth |
| P/B | 6.53 | 1.37 |
| P/S | 1.00 | 0.15 |
| EV/EBITDA | — | 7.1 |
| Revenue growth | +47.7% | +14.3% |
| Gross margin | — | 8.6% |
| Operating margin | 3.6% | 2.2% |
| Net margin | -2.6% | -2.5% |
| Return on equity | -16.8% | -22.5% |
| Return on assets | -8.2% | -6.1% |
| Return on invested capital | -13.3% | 3.7% |
| FCF yield | 2.5% | 28.9% |
| Debt / equity | 0.00 | 0.71 |
| Current ratio | 1.33 | 1.15 |
| Altman Z (solvency) | 2.66 | 3.08 |
| Piotroski F (quality) | 8 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.